Valor202020212022202320242025TTMGastos comerciales, generales y administrativos7.33 M10.36 M10.93 M13.8 M9.32 M4.02 M4.02 MInvestigación y desarrollo2.36 M2.15 M903.98 K703.82 K203.3 K203.3 K—Beneficio operativo-16.25 M-22.12 M-22.32 M-27.32 M-111.44 M-4.02 M-4.02 MTotal de ingresos no operativos-152.16 K-200.82 K166.34 K-241.3 K-2.31 M1.79 M1.79 MGastos por intereses, netos de intereses capitalizados152.37 K316.44 K291.18 K303.97 K2.29 M206.05 K206.05 KIngresos no operativos, una vez deducidos los gastos por intereses-304.73 K-632.88 K-582.35 K-607.93 K-4.57 M1.6 M1.6 MIngresos/gastos extraordinarios212115.62 K457.52 K62.66 K-28.8 K-13.39 K-13.39 KBeneficio antes de impuestos-16.4 M-22.32 M-22.16 M-27.56 M-113.75 M-2.23 M-2.44 MParticipación en los beneficios———————Impuestos0000000Participación minoritaria———————Otros ingresos/gastos después de impuestos-46.16 K-17.39 K-22.98 K-16.6 K-43.39 K374.01 K—Beneficio neto antes de actividades interrumpidas-16.4 M-22.32 M-22.16 M-27.56 M-113.75 M-2.23 M-2.23 MOperaciones suspendidas————-35.44 M-16.26 M-16.26 MBeneficio neto-16.4 M-22.32 M-22.16 M-27.56 M-149.19 M-18.49 M-18.49 MAjuste por dilución———————Dividendos de las acciones preferentes———————Beneficio neto diluido atribuible a los accionistas-16.4 M-22.32 M-22.16 M-27.56 M-149.19 M-18.49 M-18.49 MBeneficio básico por acción———-7.17-38.65-4.77-4.77Beneficio por acción diluido—-412.67-6.2-7.17-38.65-4.77-4.77Número medio de acciones ordinarias———3.84 M3.86 M3.87 M15.49 MAcciones diluidas—54.09 K3.55 M3.84 M3.86 M3.87 M15.49 MEBITDA-14.75 M-20.33 M-20.3 M-25.16 M—-1.11 M-1.97 MEBIT-16.25 M-22.12 M-22.32 M-27.32 M—-2.01 M-2.01 MCosto de los ingresos———15.28 M—-2.01 M-2.01 MOtros costes de producción———15.28 M———Amortización y depreciación (flujo de caja)1.49 M1.79 M2.02 M2.16 M904.14 K904.14 K—
AquaBounty Technologies Inc
AquaBounty Technologies is a biotechnology and aquaculture company based in Maynard, Massachusetts, United States. The company is notable for its research and development of genetically modified fish. It aims to create products that aim to increase the productivity of aquaculture. As of 2020, sale of the company's AquAdvantage salmon has been approved in Canada and the United States. The company sold all of its operating farms and ceased fish production in 2024.